Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Clinical trial NCT03008148 · UNKNOWN
Trial details
- NCT number
- NCT03008148
- Sponsor
- Johnpro Biotech, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-11
- Primary completion
- 2025-04-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.